Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer

Radionuclides that emit alpha particles (charged helium nuclei) are currently used clinically to treat cancers including prostate cancer. Here, the authors combine a humanized antibody to an alpha particle emitter, specifically to target a downstream effector of the androgen receptor and create a fe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michael R. McDevitt, Daniel L. J. Thorek, Takeshi Hashimoto, Tatsuo Gondo, Darren R. Veach, Sai Kiran Sharma, Teja Muralidhar Kalidindi, Diane S. Abou, Philip A. Watson, Bradley J. Beattie, Oskar Vilhemsson Timmermand, Sven-Erik Strand, Jason S. Lewis, Peter T. Scardino, Howard I. Scher, Hans Lilja, Steven M. Larson, David Ulmert
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/02a356c6cc14425c8da1a1e7764743bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:02a356c6cc14425c8da1a1e7764743bc
record_format dspace
spelling oai:doaj.org-article:02a356c6cc14425c8da1a1e7764743bc2021-12-02T16:50:08ZFeed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer10.1038/s41467-018-04107-w2041-1723https://doaj.org/article/02a356c6cc14425c8da1a1e7764743bc2018-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-04107-whttps://doaj.org/toc/2041-1723Radionuclides that emit alpha particles (charged helium nuclei) are currently used clinically to treat cancers including prostate cancer. Here, the authors combine a humanized antibody to an alpha particle emitter, specifically to target a downstream effector of the androgen receptor and create a feed forward loop that increases the therapeutic efficacy.Michael R. McDevittDaniel L. J. ThorekTakeshi HashimotoTatsuo GondoDarren R. VeachSai Kiran SharmaTeja Muralidhar KalidindiDiane S. AbouPhilip A. WatsonBradley J. BeattieOskar Vilhemsson TimmermandSven-Erik StrandJason S. LewisPeter T. ScardinoHoward I. ScherHans LiljaSteven M. LarsonDavid UlmertNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Michael R. McDevitt
Daniel L. J. Thorek
Takeshi Hashimoto
Tatsuo Gondo
Darren R. Veach
Sai Kiran Sharma
Teja Muralidhar Kalidindi
Diane S. Abou
Philip A. Watson
Bradley J. Beattie
Oskar Vilhemsson Timmermand
Sven-Erik Strand
Jason S. Lewis
Peter T. Scardino
Howard I. Scher
Hans Lilja
Steven M. Larson
David Ulmert
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
description Radionuclides that emit alpha particles (charged helium nuclei) are currently used clinically to treat cancers including prostate cancer. Here, the authors combine a humanized antibody to an alpha particle emitter, specifically to target a downstream effector of the androgen receptor and create a feed forward loop that increases the therapeutic efficacy.
format article
author Michael R. McDevitt
Daniel L. J. Thorek
Takeshi Hashimoto
Tatsuo Gondo
Darren R. Veach
Sai Kiran Sharma
Teja Muralidhar Kalidindi
Diane S. Abou
Philip A. Watson
Bradley J. Beattie
Oskar Vilhemsson Timmermand
Sven-Erik Strand
Jason S. Lewis
Peter T. Scardino
Howard I. Scher
Hans Lilja
Steven M. Larson
David Ulmert
author_facet Michael R. McDevitt
Daniel L. J. Thorek
Takeshi Hashimoto
Tatsuo Gondo
Darren R. Veach
Sai Kiran Sharma
Teja Muralidhar Kalidindi
Diane S. Abou
Philip A. Watson
Bradley J. Beattie
Oskar Vilhemsson Timmermand
Sven-Erik Strand
Jason S. Lewis
Peter T. Scardino
Howard I. Scher
Hans Lilja
Steven M. Larson
David Ulmert
author_sort Michael R. McDevitt
title Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
title_short Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
title_full Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
title_fullStr Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
title_full_unstemmed Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
title_sort feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/02a356c6cc14425c8da1a1e7764743bc
work_keys_str_mv AT michaelrmcdevitt feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT danielljthorek feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT takeshihashimoto feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT tatsuogondo feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT darrenrveach feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT saikiransharma feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT tejamuralidharkalidindi feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT dianesabou feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT philipawatson feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT bradleyjbeattie feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT oskarvilhemssontimmermand feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT svenerikstrand feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT jasonslewis feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT petertscardino feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT howardischer feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT hanslilja feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT stevenmlarson feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
AT davidulmert feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer
_version_ 1718383077302992896